Community post

Marzanna Lusiak-Szelachowska (Hirszfeld Institute of Immunology and Experimental Therapy) and colleagues published a new paper on antiphage antibodies in phage therapy patients, showing antibodies appear late in treatment, particularly with local or combined local/oral administration, without preventing positive outcomes.